BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27631800)

  • 1. Real-Time Surface Plasmon Resonance (SPR) for the Analysis of Interactions Between SUMO Traps and Mono- or PolySUMO Moieties.
    Xolalpa W; Rodriguez MS; England P
    Methods Mol Biol; 2016; 1475():99-107. PubMed ID: 27631800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Biotinylated SUMO-Traps to Analyze SUMOylated Proteins.
    Lang V; Da Silva-Ferrada E; Barrio R; Sutherland JD; Rodriguez MS
    Methods Mol Biol; 2016; 1475():109-21. PubMed ID: 27631801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Characterization of SUMO-SIM Interactions.
    Husnjak K; Keiten-Schmitz J; Müller S
    Methods Mol Biol; 2016; 1475():79-98. PubMed ID: 27631799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
    Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
    J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Characterization of Chain Depolymerization Activities of SUMO-Specific Proteases.
    Eckhoff J; Dohmen RJ
    Methods Mol Biol; 2016; 1475():123-35. PubMed ID: 27631802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and Purification of Recombinant SUMOylated Proteins Using Engineered Bacteria.
    Brockly F; Piechaczyk M; Bossis G
    Methods Mol Biol; 2016; 1475():55-65. PubMed ID: 27631797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Multimeric Protein Scaffolds for Identifying Multi-SUMO Binding Proteins.
    Aguilar-Martínez E; Sharrocks AD
    Methods Mol Biol; 2016; 1475():195-204. PubMed ID: 27631807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for the expression of SUMO-modified target proteins in Escherichia coli.
    Saitoh H; Uwada J; Azusa K
    Methods Mol Biol; 2009; 497():211-21. PubMed ID: 19107420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of SUMOylated Proteins in Cells and In Vivo Using the bioSUMO Strategy.
    Pirone L; Xolalpa W; Mayor U; Barrio R; Sutherland JD
    Methods Mol Biol; 2016; 1475():161-9. PubMed ID: 27631805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity.
    Berta MA; Mazure N; Hattab M; Pouysségur J; Brahimi-Horn MC
    Biochem Biophys Res Commun; 2007 Aug; 360(3):646-52. PubMed ID: 17610843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Histone Deacetylases Sumoylation by Immunoprecipitation Techniques.
    Wagner T; Godmann M; Heinzel T
    Methods Mol Biol; 2017; 1510():339-351. PubMed ID: 27761833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-Free Identification and Quantification of SUMO Target Proteins.
    Hendriks IA; Vertegaal AC
    Methods Mol Biol; 2016; 1475():171-93. PubMed ID: 27631806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer.
    Lopitz-Otsoa F; Delgado TC; Lachiondo-Ortega S; Azkargorta M; Elortza F; Rodríguez MS; Martínez-Chantar ML
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay methods for small ubiquitin-like modifier (SUMO)-SUMO-interacting motif (SIM) interactions in vivo and in vitro using a split-luciferase complementation system.
    Hirohama M; Voet AR; Ozawa T; Saitoh H; Nakao Y; Zhang KY; Ito A; Yoshida M
    Anal Biochem; 2014 Mar; 448():92-4. PubMed ID: 24333278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human SUMO fusion systems enhance protein expression and solubility.
    Wang Z; Li H; Guan W; Ling H; Wang Z; Mu T; Shuler FD; Fang X
    Protein Expr Purif; 2010 Oct; 73(2):203-8. PubMed ID: 20457256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncovalent structure of SENP1 in complex with SUMO2.
    Ambaye ND
    Acta Crystallogr F Struct Biol Commun; 2019 May; 75(Pt 5):332-339. PubMed ID: 31045562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of SUMO-1 modified IκBα and complex formation with NF-κB.
    Lens Z; Dewitte F; Van Lint C; de Launoit Y; Villeret V; Verger A
    Protein Expr Purif; 2011 Dec; 80(2):211-6. PubMed ID: 21708266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of SUMOylated proteins using SUMO-traps.
    Da Silva-Ferrada E; Xolalpa W; Lang V; Aillet F; Martin-Ruiz I; de la Cruz-Herrera CF; Lopitz-Otsoa F; Carracedo A; Goldenberg SJ; Rivas C; England P; Rodríguez MS
    Sci Rep; 2013; 3():1690. PubMed ID: 23604351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.